Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional Study to Investigate the Current Situation of Asthma-COPD Overlap Syndrome in Patients Over Age 40 With Persistent Airflow Limitation in China

NCT02600221 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT02600221
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02600221 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional Study to Investigate the Current Situation of Asthma-COPD Overlap Syndrome in Patients Over Age 40 With Persistent Airflow Limitation in China
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
October 22, 2015
Completion date
October 24, 2016
Enrollment
2,016 (actual)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

asthma-copd overlap syndrome